Home > Insider Trading > Filing (0001576280-21-000013)

Filing Details

Accession Number:: 0001576280-21-000013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-05 17:03:20
Reporting Period:: 2020-12-02

Accepted Time:: 2021-02-05 17:03:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	505 Penobscot Drive Redwood City CA 94063	Chairman, President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-12-02	92,603	$0.00	2,530,280	No	5	G	Direct
Common Stock	Disposition	2020-12-27	25,000	$0.00	2,505,280	No	5	G	Direct
Common Stock	Disposition	2021-02-03	1,712	$156.92	2,503,568	No	4	S	Direct
Common Stock	Disposition	2021-02-03	31,156	$157.93	2,472,412	No	4	S	Direct
Common Stock	Disposition	2021-02-03	11,074	$158.75	2,461,338	No	4	S	Direct
Common Stock	Disposition	2021-02-03	32,638	$159.54	2,428,700	No	4	S	Direct
Common Stock	Disposition	2021-02-03	335	$160.55	2,428,365	No	4	S	Direct
Common Stock	Disposition	2021-02-03	246	$156.94	586,787	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-03	4,606	$157.93	582,181	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-03	1,657	$158.75	580,524	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-03	4,944	$159.53	575,580	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-03	9	$160.55	575,571	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-04	13,594	$157.76	2,414,771	No	4	S	Direct
Common Stock	Disposition	2021-02-04	18,180	$158.76	2,396,591	No	4	S	Direct
Common Stock	Disposition	2021-02-04	14,051	$159.58	2,382,540	No	4	S	Direct
Common Stock	Disposition	2021-02-04	1,228	$160.12	2,381,312	No	4	S	Direct
Common Stock	Disposition	2021-02-04	2,016	$157.76	573,555	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-04	2,689	$158.76	570,866	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-04	2,054	$159.58	568,812	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2021-02-04	211	$160.12	568,601	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.36 to $157.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.3684 to $158.3606, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.37 to $159.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.37 to $160.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.07 to $158.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.07 to $159.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.07 to $160.055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.07 to $160.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.